ArticleCardiovascular diabetology2020

How should we monitor the cardiovascular benefit of sodium-glucose cotransporter 2 inhibition?

Atsushi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.